Retinopathy of prematurity
•Download as PPTX, PDF•
2 likes•142 views
This document provides an overview of Retinopathy of Prematurity (ROP), which is a vascular disorder of the retina that occurs primarily in preterm infants. ROP can potentially lead to permanent blindness if not treated properly. The document discusses who is at risk for ROP, including preterm infants born before 34 weeks gestation or weighing less than 2kg. It outlines recommended screening guidelines to detect ROP, including screening all high-risk infants by one month of age. Timely screening and treatment can prevent blindness in most cases of ROP.
Report
Share
Report
Share
Recommended
Miracle
Retinopathy of prematurity (ROP) is a potentially blinding eye disease that affects premature infants. It occurs when the retinal blood vessels in very premature infants grow abnormally and cause scarring at the back of the eye. If left untreated, ROP can cause retinal detachment and blindness. Screening examinations are recommended for high-risk preterm infants to detect ROP early when it is most treatable. Treatment options include laser photocoagulation, cryotherapy, or in severe cases, surgery to prevent blindness from ROP.
ROP current understanding and management
Retinopathy of prematurity (ROP) is a vascular disease of the eye unique to preterm infants characterized by failure of retinal blood vessels to grow and develop normally. It results in severe visual impairment and blindness in newborns.
Retinopathy of prematurity
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Dr Azad on ROP: Need for training and screening
This document discusses the need for training and screening in retinopathy of prematurity (ROP). It notes that ROP is a major cause of preventable childhood blindness worldwide. While developed countries have screening programs that detect ROP early, many developing countries lack adequate screening. The document outlines the magnitude of the problem in India, where millions of premature infants are at risk of ROP but screening capacity is limited. It emphasizes the need to train more ophthalmologists and neonatologists to conduct ROP screening according to standardized protocols. Workshops have helped boost awareness and establish new screening centers, but more infrastructure and manpower are still needed to address the growing ROP burden in India. Regular screening can detect ROP before
Retinopathy of prematurity by dr. tareq rahman
Retinopathy of prematurity (ROP) is a retinal vascular disorder that occurs primarily in preterm infants. It develops due to interrupted retinal vascularization and abnormal blood vessel growth caused by premature birth. Infants with very low birth weight (<1500g) or gestational age (<32 weeks) are most at risk. If left untreated, ROP can cause blindness or severe vision impairment. Screening, timely diagnosis, and treatment with laser photocoagulation or anti-VEGF injections can help prevent vision loss from ROP.
Update on retinopathy of prematurity
This document summarizes recent developments in retinopathy of prematurity (ROP). It discusses that ROP cases are increasing in the US due to declining infant mortality. Imaging techniques now allow wide-angle retinal imaging. Telemedicine enables remote diagnosis of ROP. Anti-VEGF treatments show promise but require more research on dosage and side effects. Future areas of study include genetics, epigenetics, stem cells, and using artificial intelligence for remote image grading to manage increasing ROP cases.
Rop screening ppt
This document discusses retinopathy of prematurity (ROP), a retinal disorder primarily affecting preterm and low birth weight babies. ROP is a leading cause of childhood blindness globally. Key risk factors include prematurity, low birth weight, and prolonged oxygen therapy. The document outlines screening guidelines for ROP, including which infants should be screened based on gestational age and birth weight. It describes the examination procedure and classification system used to stage ROP based on location and severity. Treatment thresholds and follow up schedules are also discussed.
retinopathy of prematurity
The document summarizes guidelines and recommendations for screening, diagnosing, and treating retinopathy of prematurity (ROP). ROP is a leading cause of childhood blindness that affects premature infants. It occurs when the retina is incompletely developed and blood vessels have not fully grown. The summary discusses screening criteria and stages of ROP diagnosis using the International Classification. Treatment options include cryotherapy, laser photocoagulation, anti-VEGF injections, and surgery. Clinical trials demonstrated that early treatment of high-risk prethreshold ROP reduces unfavorable visual outcomes.
Recommended
Miracle
Retinopathy of prematurity (ROP) is a potentially blinding eye disease that affects premature infants. It occurs when the retinal blood vessels in very premature infants grow abnormally and cause scarring at the back of the eye. If left untreated, ROP can cause retinal detachment and blindness. Screening examinations are recommended for high-risk preterm infants to detect ROP early when it is most treatable. Treatment options include laser photocoagulation, cryotherapy, or in severe cases, surgery to prevent blindness from ROP.
ROP current understanding and management
Retinopathy of prematurity (ROP) is a vascular disease of the eye unique to preterm infants characterized by failure of retinal blood vessels to grow and develop normally. It results in severe visual impairment and blindness in newborns.
Retinopathy of prematurity
Retinopathy of prematurity (ROP), initially described as retrolental fibroplasia one of the leading cause of blindness in children.
Despite advances in diagnosis and treatment, as medicine and technology advances and premature infants are surviving at earlier gestational ages, ROP continues to be a significant problem.
ROP results in disorganized growth of retinal blood vessels, which may lead to scarring and retinal detachment.
Dr Azad on ROP: Need for training and screening
This document discusses the need for training and screening in retinopathy of prematurity (ROP). It notes that ROP is a major cause of preventable childhood blindness worldwide. While developed countries have screening programs that detect ROP early, many developing countries lack adequate screening. The document outlines the magnitude of the problem in India, where millions of premature infants are at risk of ROP but screening capacity is limited. It emphasizes the need to train more ophthalmologists and neonatologists to conduct ROP screening according to standardized protocols. Workshops have helped boost awareness and establish new screening centers, but more infrastructure and manpower are still needed to address the growing ROP burden in India. Regular screening can detect ROP before
Retinopathy of prematurity by dr. tareq rahman
Retinopathy of prematurity (ROP) is a retinal vascular disorder that occurs primarily in preterm infants. It develops due to interrupted retinal vascularization and abnormal blood vessel growth caused by premature birth. Infants with very low birth weight (<1500g) or gestational age (<32 weeks) are most at risk. If left untreated, ROP can cause blindness or severe vision impairment. Screening, timely diagnosis, and treatment with laser photocoagulation or anti-VEGF injections can help prevent vision loss from ROP.
Update on retinopathy of prematurity
This document summarizes recent developments in retinopathy of prematurity (ROP). It discusses that ROP cases are increasing in the US due to declining infant mortality. Imaging techniques now allow wide-angle retinal imaging. Telemedicine enables remote diagnosis of ROP. Anti-VEGF treatments show promise but require more research on dosage and side effects. Future areas of study include genetics, epigenetics, stem cells, and using artificial intelligence for remote image grading to manage increasing ROP cases.
Rop screening ppt
This document discusses retinopathy of prematurity (ROP), a retinal disorder primarily affecting preterm and low birth weight babies. ROP is a leading cause of childhood blindness globally. Key risk factors include prematurity, low birth weight, and prolonged oxygen therapy. The document outlines screening guidelines for ROP, including which infants should be screened based on gestational age and birth weight. It describes the examination procedure and classification system used to stage ROP based on location and severity. Treatment thresholds and follow up schedules are also discussed.
retinopathy of prematurity
The document summarizes guidelines and recommendations for screening, diagnosing, and treating retinopathy of prematurity (ROP). ROP is a leading cause of childhood blindness that affects premature infants. It occurs when the retina is incompletely developed and blood vessels have not fully grown. The summary discusses screening criteria and stages of ROP diagnosis using the International Classification. Treatment options include cryotherapy, laser photocoagulation, anti-VEGF injections, and surgery. Clinical trials demonstrated that early treatment of high-risk prethreshold ROP reduces unfavorable visual outcomes.
Retinopathy of prematurity by dr sonali paradhi mhatre
Retinopathy of prematurity (ROP) is a disease of the developing retina that results from interrupted development of retinal blood vessels. It is a leading cause of blindness in children. ROP was initially described in the 1940s and is associated with supplemental oxygen use in premature infants. The retina develops from the optic cup and retinal blood vessel growth occurs after birth. ROP occurs when normal vessel growth is disrupted, leading to abnormal neovascularization. Staging of ROP involves evaluating location, severity, extent, and presence of plus disease. Laser treatment is the standard therapy to promote vessel growth and prevent retinal detachment. Screening high-risk infants and timely treatment can help prevent vision loss from ROP.
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a retinal disorder in premature infants that can lead to vision loss. It occurs when the retina fails to properly vascularize in low birth weight preterm babies. Risk factors include being born before 32 weeks gestation or weighing less than 1500g, exposure to supplemental oxygen, and other medical complications. ROP progresses through five stages, from mild abnormal blood vessel growth to complete retinal detachment. Screening exams are conducted regularly in at-risk infants to detect ROP, and severe cases may be treated with cryotherapy or laser treatment to prevent vision loss from retinal detachment. Complications can include myopia, strabismus, and glaucoma.
Retinopathy Of Prematurity Screening
Presented by : Dr Gaurav Jain, Guide : Dr Mrunal Patil, Institute : dr vasantrao pawar medical college,nashik
Rop seminar
This document summarizes retinopathy of prematurity (ROP), including its pathogenesis, classification system, risk factors, screening guidelines, and treatment options. ROP is a retinal vascular disorder that primarily affects premature infants. It is classified based on location within the retina, severity of neovascularization, extent of disease, and presence of "plus disease". Screening is recommended for infants with certain birth weights and gestational ages. Treatment may involve laser photocoagulation, anti-VEGF injections, cryotherapy, or surgery depending on the stage of ROP. Several landmark studies have helped establish modern guidelines for ROP screening and treatment.
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a potentially blinding eye disease that affects premature infants. It occurs when the retina of premature infants develops abnormally as a result of interrupted retinal vascularization. The disease ranges in severity from mild to severe, with the most severe cases resulting in retinal detachment and blindness. Screening for ROP involves examining the retina using indirect ophthalmoscopy starting between 20-30 days of life in infants born before 34-35 weeks gestation and/or weighing 1500g or less. Treatment options depend on the stage of ROP and may include laser therapy or anti-VEGF injections to prevent further progression. Affected infants require long-term follow-up to monitor vision and eye
Retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP), including:
1. ROP is a vasoproliferative retinal disorder that is a leading cause of childhood blindness, with risk increasing in infants with lower gestational ages and birth weights.
2. It results from abnormal vascularization of the retina in premature infants, which can progress to retinal detachment if left untreated.
3. Screening and treatment guidelines are outlined, with laser photocoagulation now being the primary treatment for severe ROP to prevent blindness.
4. Prevention strategies aim to minimize risks for preterm birth and optimize oxygen levels and nutrition for premature infants to reduce the incidence and severity of ROP
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a retinal vascular disorder that primarily affects premature infants. It occurs when the retinal blood vessels in the eye are not fully developed. The summary describes the key stages and phases of ROP pathogenesis. Phase 1 involves an initial insult like hyperoxia or hypoxia that arrests retinal vascular development. Phase 2 involves neovascularization driven by hypoxic conditions in the avascular retina. Treatment includes laser photocoagulation or anti-VEGF injections to promote regression of abnormal blood vessels and prevent retinal detachment. Several clinical trials have found that early treatment of high-risk prethreshold ROP improves outcomes by reducing unfavorable anatomical and visual outcomes compared to conventional observation and treatment.
DR WANI'S TALK ON Retinopathy of prematurity
It is a comprehensive presentation about retinopathy of prematurity with Indian guidelines for screening in mind
Rop case series- DR AJAY DUDANI
This document discusses the management of retinopathy of prematurity (ROP) through a case series using anti-VEGF treatments. It begins with background on ROP and past clinical trials involving cryotherapy and supplemental oxygen therapy. It then summarizes studies using anti-VEGF injections like bevacizumab and ranibizumab to treat advanced ROP cases. The author's own case series of 17 eyes from 8 premature infants treated with pegaptanib, avastin or lucentis is presented, showing regression of neovascularization in all eyes. Potential uses of anti-VEGF discussed include primary therapy or as an adjunct to laser when laser has failed or before vitrectomy surgery to reduce bleeding. In conclusion
Retinopathy of prematurity 2014 july 11
Retinopathy of prematurity (ROP) is a blinding eye disease that affects the developing retina of premature infants. It occurs in two phases - an initial delayed growth of retinal blood vessels after birth due to exposure to high oxygen levels, followed by abnormal neovascularization due to hypoxia. Babies born at less than 30 weeks gestation or weighing less than 1500g are screened, with treatment (laser photocoagulation or cryotherapy) for severe "threshold" or "pre-threshold" ROP. Surgical options like vitrectomy may be used if laser treatment fails, but long-term follow up is still needed to monitor for complications.
Retinopathy of prematurity rop satish 1
This document provides an overview of retinopathy of prematurity (ROP), including its pathogenesis, classification, diagnosis, screening protocols, timing of treatment, and prevention strategies. ROP is a vasoproliferative retinal disorder that predominantly affects premature infants. It occurs as a result of abnormal retinal vascular development caused by oxidative stress and hypoxia. The classification system involves evaluating the location and stage of the disease along with any presence of "plus disease". Screening protocols are based on gestational age and postmenstrual age to detect ROP in its early stages to guide timely treatment and prevent vision loss.
Retinopathy of prematurity (upload for site)
Retinopathy of prematurity (ROP) is a disease of the developing retina in premature infants. It was originally caused by high concentrations of supplemental oxygen, but is now a multifactorial condition influenced by prematurity. Immature retinal blood vessels are susceptible to injury from oxygen and growth factors like VEGF and IGF regulate normal vessel development. Supplemental oxygen can disrupt this process and cause abnormal vessel growth leading to ROP. Stages of ROP describe the progression from initial vascular changes to retinal detachment. Treatment with cryotherapy or laser therapy aims to stop progressive ROP before it reaches the threshold stage. While treatment prevents vision loss, ROP can still cause complications like myopia, strabismus and amblyopia
Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is an abnormal proliferation of retinal blood vessels in preterm infants that can lead to blindness. It occurs when the retinal blood vessels in preterm infants are incompletely developed and then exposed to high oxygen levels. Risk factors include low gestational age, low birth weight, and supplemental oxygen therapy. ROP is diagnosed through screening exams of at-risk infants and graded based on location, stage of progression, and extent of involvement. Treatment options include laser therapy, anti-VEGF injections, or surgery depending on the severity. Long term management may also involve low vision services if vision is significantly impacted.
Retinopathy of prematurity
This document discusses retinopathy of prematurity (ROP), which is a disease of the retinal vasculature that can occur in premature infants. It causes interrupted retinal vascularization that leads to abnormal neovascularization. The document covers the pathogenesis, risk factors, classification system, screening guidelines, and treatments for ROP, including retinal ablation using cryotherapy or laser, scleral buckling, and vitrectomy. Effective screening and timely treatment can help prevent ROP from progressing and potentially causing blindness.
Retinopathy of prematurity
trying to cover basics of the disease - includes pathology, presentation , classification, screening, management
seminar on ROP - retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP). It begins with a case scenario of an infant diagnosed with ROP and treated during their NICU course. It then discusses the history, incidence, risk factors, classification, diagnosis, screening criteria, and treatment of ROP. The presentation covers the embryology of retinal vessels, pathogenesis of ROP, international classification system for ROP (including zones, stages, plus disease), screening recommendations, treatment modalities including laser photocoagulation and cryotherapy, and prognosis. The goal of the document is to provide attendees with a comprehensive understanding of ROP.
Retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP), including its pathogenesis, risk factors, classification system, screening guidelines, and treatment approaches. ROP is a proliferative retinopathy that affects premature infants and can lead to blindness. It occurs due to incomplete vascularization of the retina at birth. The classification system involves zones, stages, and presence of "plus disease". Screening is recommended for infants with birth weight <1500g or gestational age <30 weeks. Treatment involves ablating the peripheral retina using cryotherapy or laser photocoagulation to remove the stimulus for abnormal blood vessel growth.
Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a retinal vascular disorder in premature infants. It was first described in the 1950s when premature babies received high oxygen supplementation. The retinal vasculature normally develops from week 16-40 of gestation. In ROP, immature retinal tissue is exposed to high oxygen, causing vaso-obliteration, then neovascularization when oxygen levels decrease. ROP is classified by location, stage of severity, and extent. Treatment is usually cryotherapy or laser photocoagulation for severe cases. Anti-VEGF is also used and may reduce recurrence rates compared to laser. Follow-up exams are needed based on risk factors.
Rop – emerging therapies march 2011
This is a presentation given at the teaching programme for Ophthalmologists in training at the Royal Victoria Eye and Ear Hospital, March 2011. It covers new developments in the treatment of Retinopathy of Prematurity.
Rop
This document discusses retinopathy of prematurity (ROP), including:
1. A case of ROP is presented with fundus examination findings over multiple dates. Laser treatment was performed on the left eye.
2. The classification of ROP is explained according to the International Classification of ROP including zone, severity, extent, plus disease, and pre-plus disease. Threshold disease requiring treatment is defined.
3. Screening, examination, and treatment guidelines for ROP are outlined including who to screen, timing of exams, examination procedure and documentation, and treatment indications. Cryotherapy and laser ablation are discussed as standard treatments.
Screening
Vision screening is important to identify vision impairments in children so they can receive treatment. Screening should begin at birth and continue at well-child visits. Early screening can detect conditions like amblyopia, which is most effectively treated in early childhood. While only 21% of preschoolers receive vision screening, screening is highly cost-effective for detecting and treating amblyopia and other vision issues. Pediatricians play a key role in regularly screening children's vision as part of comprehensive well-child care.
Before neonatal discharge
The document discusses guidelines for discharging neonates from the hospital. It outlines several criteria that should be met before discharge, including the infant being physiologically stable and able to feed adequately. Important screening tests that must be completed prior to discharge include pulse oximetry for congenital heart disease, examination for developmental dysplasia of the hip, and checking the red reflex. The guidelines aim to ensure neonates are ready based on developmental factors rather than just weight before being discharged from the hospital.
More Related Content
What's hot
Retinopathy of prematurity by dr sonali paradhi mhatre
Retinopathy of prematurity (ROP) is a disease of the developing retina that results from interrupted development of retinal blood vessels. It is a leading cause of blindness in children. ROP was initially described in the 1940s and is associated with supplemental oxygen use in premature infants. The retina develops from the optic cup and retinal blood vessel growth occurs after birth. ROP occurs when normal vessel growth is disrupted, leading to abnormal neovascularization. Staging of ROP involves evaluating location, severity, extent, and presence of plus disease. Laser treatment is the standard therapy to promote vessel growth and prevent retinal detachment. Screening high-risk infants and timely treatment can help prevent vision loss from ROP.
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a retinal disorder in premature infants that can lead to vision loss. It occurs when the retina fails to properly vascularize in low birth weight preterm babies. Risk factors include being born before 32 weeks gestation or weighing less than 1500g, exposure to supplemental oxygen, and other medical complications. ROP progresses through five stages, from mild abnormal blood vessel growth to complete retinal detachment. Screening exams are conducted regularly in at-risk infants to detect ROP, and severe cases may be treated with cryotherapy or laser treatment to prevent vision loss from retinal detachment. Complications can include myopia, strabismus, and glaucoma.
Retinopathy Of Prematurity Screening
Presented by : Dr Gaurav Jain, Guide : Dr Mrunal Patil, Institute : dr vasantrao pawar medical college,nashik
Rop seminar
This document summarizes retinopathy of prematurity (ROP), including its pathogenesis, classification system, risk factors, screening guidelines, and treatment options. ROP is a retinal vascular disorder that primarily affects premature infants. It is classified based on location within the retina, severity of neovascularization, extent of disease, and presence of "plus disease". Screening is recommended for infants with certain birth weights and gestational ages. Treatment may involve laser photocoagulation, anti-VEGF injections, cryotherapy, or surgery depending on the stage of ROP. Several landmark studies have helped establish modern guidelines for ROP screening and treatment.
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a potentially blinding eye disease that affects premature infants. It occurs when the retina of premature infants develops abnormally as a result of interrupted retinal vascularization. The disease ranges in severity from mild to severe, with the most severe cases resulting in retinal detachment and blindness. Screening for ROP involves examining the retina using indirect ophthalmoscopy starting between 20-30 days of life in infants born before 34-35 weeks gestation and/or weighing 1500g or less. Treatment options depend on the stage of ROP and may include laser therapy or anti-VEGF injections to prevent further progression. Affected infants require long-term follow-up to monitor vision and eye
Retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP), including:
1. ROP is a vasoproliferative retinal disorder that is a leading cause of childhood blindness, with risk increasing in infants with lower gestational ages and birth weights.
2. It results from abnormal vascularization of the retina in premature infants, which can progress to retinal detachment if left untreated.
3. Screening and treatment guidelines are outlined, with laser photocoagulation now being the primary treatment for severe ROP to prevent blindness.
4. Prevention strategies aim to minimize risks for preterm birth and optimize oxygen levels and nutrition for premature infants to reduce the incidence and severity of ROP
Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a retinal vascular disorder that primarily affects premature infants. It occurs when the retinal blood vessels in the eye are not fully developed. The summary describes the key stages and phases of ROP pathogenesis. Phase 1 involves an initial insult like hyperoxia or hypoxia that arrests retinal vascular development. Phase 2 involves neovascularization driven by hypoxic conditions in the avascular retina. Treatment includes laser photocoagulation or anti-VEGF injections to promote regression of abnormal blood vessels and prevent retinal detachment. Several clinical trials have found that early treatment of high-risk prethreshold ROP improves outcomes by reducing unfavorable anatomical and visual outcomes compared to conventional observation and treatment.
DR WANI'S TALK ON Retinopathy of prematurity
It is a comprehensive presentation about retinopathy of prematurity with Indian guidelines for screening in mind
Rop case series- DR AJAY DUDANI
This document discusses the management of retinopathy of prematurity (ROP) through a case series using anti-VEGF treatments. It begins with background on ROP and past clinical trials involving cryotherapy and supplemental oxygen therapy. It then summarizes studies using anti-VEGF injections like bevacizumab and ranibizumab to treat advanced ROP cases. The author's own case series of 17 eyes from 8 premature infants treated with pegaptanib, avastin or lucentis is presented, showing regression of neovascularization in all eyes. Potential uses of anti-VEGF discussed include primary therapy or as an adjunct to laser when laser has failed or before vitrectomy surgery to reduce bleeding. In conclusion
Retinopathy of prematurity 2014 july 11
Retinopathy of prematurity (ROP) is a blinding eye disease that affects the developing retina of premature infants. It occurs in two phases - an initial delayed growth of retinal blood vessels after birth due to exposure to high oxygen levels, followed by abnormal neovascularization due to hypoxia. Babies born at less than 30 weeks gestation or weighing less than 1500g are screened, with treatment (laser photocoagulation or cryotherapy) for severe "threshold" or "pre-threshold" ROP. Surgical options like vitrectomy may be used if laser treatment fails, but long-term follow up is still needed to monitor for complications.
Retinopathy of prematurity rop satish 1
This document provides an overview of retinopathy of prematurity (ROP), including its pathogenesis, classification, diagnosis, screening protocols, timing of treatment, and prevention strategies. ROP is a vasoproliferative retinal disorder that predominantly affects premature infants. It occurs as a result of abnormal retinal vascular development caused by oxidative stress and hypoxia. The classification system involves evaluating the location and stage of the disease along with any presence of "plus disease". Screening protocols are based on gestational age and postmenstrual age to detect ROP in its early stages to guide timely treatment and prevent vision loss.
Retinopathy of prematurity (upload for site)
Retinopathy of prematurity (ROP) is a disease of the developing retina in premature infants. It was originally caused by high concentrations of supplemental oxygen, but is now a multifactorial condition influenced by prematurity. Immature retinal blood vessels are susceptible to injury from oxygen and growth factors like VEGF and IGF regulate normal vessel development. Supplemental oxygen can disrupt this process and cause abnormal vessel growth leading to ROP. Stages of ROP describe the progression from initial vascular changes to retinal detachment. Treatment with cryotherapy or laser therapy aims to stop progressive ROP before it reaches the threshold stage. While treatment prevents vision loss, ROP can still cause complications like myopia, strabismus and amblyopia
Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is an abnormal proliferation of retinal blood vessels in preterm infants that can lead to blindness. It occurs when the retinal blood vessels in preterm infants are incompletely developed and then exposed to high oxygen levels. Risk factors include low gestational age, low birth weight, and supplemental oxygen therapy. ROP is diagnosed through screening exams of at-risk infants and graded based on location, stage of progression, and extent of involvement. Treatment options include laser therapy, anti-VEGF injections, or surgery depending on the severity. Long term management may also involve low vision services if vision is significantly impacted.
Retinopathy of prematurity
This document discusses retinopathy of prematurity (ROP), which is a disease of the retinal vasculature that can occur in premature infants. It causes interrupted retinal vascularization that leads to abnormal neovascularization. The document covers the pathogenesis, risk factors, classification system, screening guidelines, and treatments for ROP, including retinal ablation using cryotherapy or laser, scleral buckling, and vitrectomy. Effective screening and timely treatment can help prevent ROP from progressing and potentially causing blindness.
Retinopathy of prematurity
trying to cover basics of the disease - includes pathology, presentation , classification, screening, management
seminar on ROP - retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP). It begins with a case scenario of an infant diagnosed with ROP and treated during their NICU course. It then discusses the history, incidence, risk factors, classification, diagnosis, screening criteria, and treatment of ROP. The presentation covers the embryology of retinal vessels, pathogenesis of ROP, international classification system for ROP (including zones, stages, plus disease), screening recommendations, treatment modalities including laser photocoagulation and cryotherapy, and prognosis. The goal of the document is to provide attendees with a comprehensive understanding of ROP.
Retinopathy of prematurity
This document provides an overview of retinopathy of prematurity (ROP), including its pathogenesis, risk factors, classification system, screening guidelines, and treatment approaches. ROP is a proliferative retinopathy that affects premature infants and can lead to blindness. It occurs due to incomplete vascularization of the retina at birth. The classification system involves zones, stages, and presence of "plus disease". Screening is recommended for infants with birth weight <1500g or gestational age <30 weeks. Treatment involves ablating the peripheral retina using cryotherapy or laser photocoagulation to remove the stimulus for abnormal blood vessel growth.
Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a retinal vascular disorder in premature infants. It was first described in the 1950s when premature babies received high oxygen supplementation. The retinal vasculature normally develops from week 16-40 of gestation. In ROP, immature retinal tissue is exposed to high oxygen, causing vaso-obliteration, then neovascularization when oxygen levels decrease. ROP is classified by location, stage of severity, and extent. Treatment is usually cryotherapy or laser photocoagulation for severe cases. Anti-VEGF is also used and may reduce recurrence rates compared to laser. Follow-up exams are needed based on risk factors.
Rop – emerging therapies march 2011
This is a presentation given at the teaching programme for Ophthalmologists in training at the Royal Victoria Eye and Ear Hospital, March 2011. It covers new developments in the treatment of Retinopathy of Prematurity.
Rop
This document discusses retinopathy of prematurity (ROP), including:
1. A case of ROP is presented with fundus examination findings over multiple dates. Laser treatment was performed on the left eye.
2. The classification of ROP is explained according to the International Classification of ROP including zone, severity, extent, plus disease, and pre-plus disease. Threshold disease requiring treatment is defined.
3. Screening, examination, and treatment guidelines for ROP are outlined including who to screen, timing of exams, examination procedure and documentation, and treatment indications. Cryotherapy and laser ablation are discussed as standard treatments.
What's hot (20)
Retinopathy of prematurity by dr sonali paradhi mhatre
Retinopathy of prematurity by dr sonali paradhi mhatre
Similar to Retinopathy of prematurity
Screening
Vision screening is important to identify vision impairments in children so they can receive treatment. Screening should begin at birth and continue at well-child visits. Early screening can detect conditions like amblyopia, which is most effectively treated in early childhood. While only 21% of preschoolers receive vision screening, screening is highly cost-effective for detecting and treating amblyopia and other vision issues. Pediatricians play a key role in regularly screening children's vision as part of comprehensive well-child care.
Before neonatal discharge
The document discusses guidelines for discharging neonates from the hospital. It outlines several criteria that should be met before discharge, including the infant being physiologically stable and able to feed adequately. Important screening tests that must be completed prior to discharge include pulse oximetry for congenital heart disease, examination for developmental dysplasia of the hip, and checking the red reflex. The guidelines aim to ensure neonates are ready based on developmental factors rather than just weight before being discharged from the hospital.
Retinopathy of prematurity recommendations for screening
This document discusses retinopathy of prematurity (ROP), including its causes, risk factors, screening recommendations, and treatment. ROP occurs when abnormal blood vessels grow in the retina of premature infants. Key points include: ROP screening is recommended for infants born before 34 weeks gestation or weighing less than 1750g; screening should begin between 3-4 weeks of life and continue until 44 weeks; laser photocoagulation or anti-VEGF treatment may be used depending on the severity and location of the ROP. Preventive measures include maintaining oxygen saturation between 88-92% and aggressive nutrition support for premature infants.
Neonatal Fever - Dr. Jeremy Brady
- Baby Fever discusses evaluating and managing febrile infants less than 90 days old. Key points include:
- For infants less than 29 days, a full septic workup is recommended including blood and urine cultures and lumbar puncture. Antibiotics and admission are typically warranted.
- Infants 29-60 days can use validated criteria like Rochester criteria to determine low risk for serious bacterial infection and potentially avoid antibiotics and admission.
- Infants under 90 days presenting with fever still have risk of urinary tract infections and should receive a urinalysis and urine culture.
INFANTS OF DIABETIC MOTHER.pdf
This document discusses infants born to mothers with diabetes. It defines infants of diabetic mothers as babies at risk of problems due to their mother's diabetes during pregnancy. It describes the types of diabetes a mother can have, clinical features in infants like macrosomia and hypoglycemia, diagnostic tests performed, potential complications, and the importance of management, prevention, and nursing care for healthy infant outcomes.
Infants of diabetic mother
This document discusses infants born to mothers with diabetes. It defines infants of diabetic mothers as babies at risk of problems due to their mother's diabetes during pregnancy. It describes the types of diabetes a mother can have, clinical features in infants like macrosomia and hypoglycemia, diagnostic tests performed, potential complications, and the importance of management, prevention, and nursing care for healthy infant outcomes.
To BV or Not to BV
This document discusses binocular vision (BV) disorders and their treatment. It begins with an introduction noting the prevalence of BV disorders like convergence insufficiency and accommodative disorders. It then provides details on examining for and diagnosing common BV syndromes. The document reviews evidence from research studies supporting the use of vision therapy and other optometric treatments. It discusses treating amblyopia at all ages and lists various treatment modalities like lenses, prisms, and vision therapy techniques.
Newborn screening 2014
This document discusses newborn screening in India. It notes that while individually rare metabolic disorders are not uncommon collectively, occurring in approximately 1 in 1000 newborns. However, India currently lacks a nationwide newborn screening program. The document outlines the components and goals of newborn screening programs, including early detection to prevent morbidity and mortality. It provides guidance on disease selection, sample collection from heel pricks onto filter paper, and conditions in India that could be included in basic and expanded newborn screening programs.
Neonatal hearing screening
1. Newborn hearing screening allows for early detection of hearing loss, which is important as it can affect language development and social interactions. Screening tests like OAE and AABR that are inexpensive, portable and automated are used.
2. Risk factors for hearing loss include family history, neonatal intensive care, infections, syndromes etc. Any infant who does not pass the screening requires further evaluation.
3. Screening the newborns is crucial as it allows for early intervention if needed, which can improve speech and language outcomes. Pediatricians have an important role in ensuring all newborns receive and follow-up on screening.
Active management of infertility - a guide for gynecologists
This document discusses best practices for actively managing infertility. It outlines some common mistakes made in traditional approaches, such as taking a "wait and watch" approach and not fully investigating the causes of infertility. The document recommends seeing couples together, completing the full testing protocol within 2 months, and having a clear treatment plan that progresses to more aggressive options if needed. It provides guidance on effective testing strategies and interpreting test results to determine the appropriate course of treatment, with the goal of helping patients conceive. The document also discusses advanced fertility treatments like IVF and stresses the importance of a good patient-doctor relationship.
Newborn screening 2014
This document discusses newborn screening in India. It notes that while over 140 million children are born each year globally, newborn screening programs are not universally implemented in India. The document outlines the types and components of newborn screening, including education, specimen collection, laboratory testing, follow-up, and evaluation. It recommends conditions that should be included in basic and expanded newborn screening programs in India, such as congenital hypothyroidism, congenital adrenal hyperplasia, and G6PD deficiency. The goal of newborn screening is early detection to prevent morbidity, mortality, and disability.
Management of late preterm babies
This document summarizes the management of late preterm infants. Key points include monitoring infants for common complications like respiratory distress, hypoglycemia, and feeding difficulties. Supplementation with expressed breastmilk or formula is often needed due to challenges with exclusive breastfeeding. Close follow-up is important to assess growth, development, and prevent future health issues that late preterm infants are at higher risk for. Lifestyle changes and interventions during pregnancy can help prevent preterm births.
Child health
RASTRIYA BAL SWASTHYA KARYAKRAM ( RBSK )
CHILD HEALTH SCREENING AND EARLY INTERVENTION SERVICES UNDER NRHM
Pre maturity of newborn
This document provides information on prematurity in newborns, including definitions, classifications, causes, and management. It defines prematurity as birth before 37 weeks gestation. Classifications include gestational age, birthweight, and a combination of both. Causes are multifactorial involving fetal, placental, and maternal factors. General measures for preterm infants include temperature and humidity control, nutrition and fluid management, and immunizations. Complications and follow-up care are also discussed.
Childhood cataracts
childhood cataracts
how to approach
differential diagnosis
treatment
glasses prescription
amblyopia
Public Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy
An advanced introduction to public health screening programmes
Hyperbili kravitz
This document discusses neonatal hyperbilirubinemia or jaundice in newborns. It covers the physiology of bilirubin production and breakdown, risk factors for high bilirubin levels, methods for assessing risk, and therapies for treatment. Key points include the dangers of kernicterus if bilirubin crosses the blood-brain barrier, phototherapy as the main treatment, and factors like gestational age, breastfeeding and family history that influence jaundice risk.
Neonatal jaundice
This document discusses neonatal jaundice (hyperbilirubinemia) in infants. It covers the definition, causes, types (physiological vs pathological), investigations, management including phototherapy and exchange transfusion, and prevention of kernicterus. Key points include:
- Jaundice is caused by high bilirubin levels which cause yellowing of the skin and eyes. Bilirubin is produced from the breakdown of red blood cells.
- Physiological jaundice appears after 24-72 hours and is common, while pathological jaundice appears within 24 hours and requires treatment.
- Management involves phototherapy to reduce bilirubin levels or exchange transfusion for severe
Follow up of High Risk Neonates.. Dr.Padmesh
Follow up of high risk neonates is important to monitor growth and development and screen for issues. High risk neonates include those born prematurely, with low birth weight, or other medical complications. Follow up should be conducted by a team including pediatricians, psychologists, and specialists. It should begin before discharge from the hospital and continue regularly in the first years, checking feeding, growth, neurological and developmental milestones through standardized assessments.
Potential Risks And Limitations Associated With The Baby Gender Blood Test In...
With the help of this Slideshow, you will get to know if there are any risks or side effects associated with the Baby Gender Blood Test in the UK. For more information visit our website - https://blueorpink.co.uk/
Similar to Retinopathy of prematurity (20)
Retinopathy of prematurity recommendations for screening
Retinopathy of prematurity recommendations for screening
Active management of infertility - a guide for gynecologists
Active management of infertility - a guide for gynecologists
Public Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy Lecture
Potential Risks And Limitations Associated With The Baby Gender Blood Test In...
Potential Risks And Limitations Associated With The Baby Gender Blood Test In...
More from Optometry fans
SUPERFICIAL PUNCTATE KERATITIS.pdf
Superficial punctate keratitis by optometry fans site, definition of SPK, causes of superficial punctate keratitis, symptoms of superficial punctate keratitis, treatment of superficial punctate keratitis, management and treatment of SPK
Strutcture of eye
The document discusses the anatomy of the eyeball, including its dimensions, coats, segments, chambers, muscles, and muscle origins and insertions. It notes that the eyeball has three coats - fibrous, vascular, and nervous - which provide protection, nutrition, and nerve transmission. It also lists the six extraocular muscles - four recti and two oblique muscles - and provides the distances of origin and insertion from the limbus for four of the muscles.
Ocular injuries
The document discusses ocular injuries, their common causes, examination, and treatment. It covers various types of anterior segment trauma including corneal foreign bodies, abrasions, recurrent epithelial erosions, hyphema, traumatic uveitis, iris trauma, and lid and orbital injuries. Common causes are abrasion, foreign bodies, penetrating injuries, blunt trauma, and chemicals. Examination involves assessing visual acuity, lids, conjunctiva, cornea, anterior chamber, iris, lens, and intraocular pressure. Treatment depends on the type of injury but may include removal of foreign bodies, antibiotics, patching, lubricants, steroids, bed rest, and surgery to repair lacerations or reattach tissues.
Amblyopia (lazy eye)
Amblyopia, also known as lazy eye, is a vision development disorder where vision in one eye is reduced if not treated early in childhood. There are several types of amblyopia including strabismus, stimulus deprivation, anisometropic, isoametropic, and meridional amblyopia. Risk factors include premature birth, small size at birth, family history, and developmental disabilities. Treatment involves occlusion therapy to force use of the weaker eye, removing any opacity in the media, and correcting any refractive errors. If left untreated, amblyopia can cause permanent vision loss.
diabetes treatment
This document discusses treatment options for diabetic eye disease. It affects most parts of the eye and can cause visual loss through maculopathy, vitreous haemorrhage, or tractional retinal detachment. Treatment involves prevention through surveillance, screening, education, and controlling blood sugar and pressure. Intervention includes laser treatment, intravitreal anti-VEGF drugs or steroids, and retinal surgery. Medical management focuses on improving control of blood sugar, treating hypertension, stopping smoking, and attending regular screenings to reduce risks of visual impairment and other complications.
Red eye
This document provides guidance on evaluating and treating red eye. It lists important questions to ask patients about symptoms, duration, and medical history. Potential causes of red eye are grouped into categories like infection, inflammation, allergy and trauma. Based on characteristics like pain, vision changes, and whether the issue is unilateral or bilateral, the document provides differential diagnoses. It outlines examination steps and suggests considering referral for issues causing visual loss, pain, corneal involvement or no response to treatment, especially for immunocompromised patients.
Test eye structure
The document outlines the main structures of the eye including the lids and conjunctiva, cornea, iris, lens, retina, choroid, and sclera. It also lists the extraocular muscles that control eye movement including the lateral and medial rectus, superior and inferior rectus, and superior and inferior oblique muscles. Finally, it notes that the third cranial nerve activates the pupil, levator muscle, and some of the extraocular muscles.
Retina exam
This document discusses symptoms of retinal disease such as blurred vision, visual distortions, and flashes of light. It also outlines examination techniques for evaluating the retina, including using direct and indirect ophthalmoscopes, slit lamps with specialized lenses, retinal photos, ultrasound, and angiography to visualize the retina and assess diseases.
Ocular trauma
This document discusses the evaluation and management of various types of ocular trauma. It begins by outlining the learning objectives of identifying, evaluating and providing first aid to patients with eye injuries. It then covers the assessment of visual acuity and ocular examination. Various types of eyelid, orbital and globe injuries are described, along with their presentations and treatment approaches. Chemical injuries and their long term effects are also reviewed. Throughout, it emphasizes the importance of immediate evaluation and management to prevent further vision loss and proper use of personal protective equipment to prevent ocular injuries.
Leucocorias
This document discusses pediatric cataract and leucocoria (white pupil). It defines leucocoria as a white reflection seen in the pupil that could indicate an underlying condition like cataract, retinoblastoma, or persistent hyperplastic primary vitreous. The document outlines the causes, presentations, classifications, management, and visual prognosis of pediatric cataracts. It emphasizes the importance of early referral for any detected leucocoria to rule out retinoblastoma or other serious conditions and prevent amblyopia. Overall management of pediatric cataracts aims to restore vision through early surgery and amblyopia treatment for the best possible visual outcomes.
GLAUCOMA
Glaucoma can be open angle or closed angle. Open angle glaucoma includes ocular hypertension, glaucoma suspect, primary open angle, exfoliative, pigmentary, normal/low tension, and congenital/juvenile types. It is assessed using visual field testing, intraocular pressure measurement, gonioscopy, optic disc examination, and imaging like OCT. Treatment involves eye drops like prostaglandin analogs, beta blockers, and surgeries like trabeculectomy. Monitoring intervals depend on whether pressure and disease are controlled. Primary angle closure glaucoma is less common but riskier, requiring treatment like laser iridotomy.
Eye structure and function
The document outlines the basic structures and functions of the human eye. It describes the main eye structures including the lids, cornea, iris, lens, retina, choroid, and sclera. It also details the extraocular muscles that control eye movement and their corresponding cranial nerves, as well as layers of the retina such as the pigment epithelium, rods and cones, nerve fiber layer, and optic nerve. Protection of the eyes is provided by surrounding structures like the orbit, lids, sclera, cornea, and tears.
EXAMINATION OF ANTERIOR SEGMENT OF EYE
The document outlines the steps for examining the anterior segment of the eye, including taking a patient history, performing a systematic examination from front to back using magnification, light, and diagnostic drops. Key areas examined are the lids, lacrimal system, orbit, eye movements, pupil reactions, conjunctiva, cornea, anterior chamber, iris, lens, and anterior vitreous, along with refraction and tests for intraocular pressure and visual fields. Photos show examples of pathological findings that may be observed, such as giant papillae on the eyelid and corneal staining.
COMPLICATION OF CATARACT SURGERY
This document summarizes potential complications from cataract surgery, grouped into those occurring at surgery, within a week, and longer term. Complications at surgery include posterior capsule rupture, dropped nucleus, and small pupil. Within a week, potential issues are infection, high eye pressure, corneal swelling, and inflammation. Longer term risks include cystoid macular edema, retinal detachment, and unexpected conditions found on postoperative exam. The document provides examples and treatment approaches for several common complications.
ANATOMY OF CORNEA
The cornea has several layers:
1. The epithelium is the outermost layer consisting of 5-6 layers of stratified squamous cells that renew from stem cells located around the periphery.
2. The stroma makes up 90% of the cornea and contains collagen fibrils for strength and elasticity.
3. Descemet's membrane is the basement membrane of the endothelium and contains collagen and glycoprotein that can regenerate. It shows Henle fibers on its posterior surface.
4. The endothelium is the innermost single cell layer that decreases in cell density with age. Gap junctions allow for fluid regulation to maintain corneal clarity.
anatomy of eyeball
The eyeball has three concentric layers and is approximately 21-26mm in diameter. It is connected to the brain by the optic nerve and protected by the bony orbit and eyelids. The cornea is transparent and located at the center of the eyeball's anterior surface, comprising 5 layers and measuring approximately 12mm by 11mm. The sclera covers the posterior four-fifths of the eyeball and provides attachment points for the extraocular muscles. Six extraocular muscles control eye movement, with the four recti muscles originating from a common tendinous ring and inserting into the sclera, while the two oblique muscles originate from bones in the orbit.
ENUCLEATION WITH CSR
The document describes the procedures for enucleation and corneo-scleral rim excision. Enucleation involves removing the entire eye globe while preserving surrounding structures, usually due to a painful blind eye, staphyloma, or malignancy. The procedure involves aseptic preparation, peritomy, identification and cutting of extraocular muscles and optic nerve, and orbital packing. Corneo-scleral rim excision is done to harvest the cornea and scleral rim for transplantation. It involves peritomy, scleral incision 4mm from the limbus, separating the corneo-scleral rim from underlying uveal tissue, and storing in preservation medium. Both require consent
Strabismus and squint
This document discusses strabismus and squint, including the anatomy of the extraocular muscles, ocular motility, binocular vision, heterophoria, manifest squint, evaluation of strabismus cases, and treatment options. It describes the extraocular muscles, types of eye movements, binocular single vision and anomalies. It also defines and classifies heterophoria and manifest squint, discusses their etiology, symptoms, examination and treatment. Evaluation of strabismus cases and different surgical techniques are also outlined.
Strabismus and squint
This document discusses strabismus and squint, including the anatomy of the extraocular muscles, ocular motility, binocular vision, heterophoria, manifest squint, evaluation and treatment of strabismus. It describes the extraocular muscles, their nerve supply and actions. It defines uniocular and binocular eye movements. It discusses binocular single vision, fusion, stereopsis and anomalies. It defines and classifies heterophoria and manifest squint. Evaluation techniques like cover tests and estimation of angle of deviation are outlined. Causes, symptoms and treatment of heterophoria and manifest squint are described. Surgical techniques for strabismus are also summarized.
Corneal ulcer
This document summarizes information about corneal ulcers. It discusses the anatomy of the cornea and common causes of corneal infections like bacteria, viruses, fungi and parasites. Corneal ulcers occur when there is damage to the corneal epithelium allowing infection to set in. Symptoms include pain, watering, photophobia and blurred vision. Signs include swelling, hypopyon in the anterior chamber. Management involves identifying the causative organism, using topical antibiotics and cycloplegics for uncomplicated cases. More severe cases may require debridement, bandage contact lenses or keratoplasty. Complications can include glaucoma, perforation and scarring.
More from Optometry fans (20)
Recently uploaded
Hindi varnamala | hindi alphabet PPT.pdf
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Wound healing PPT
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Leveraging Generative AI to Drive Nonprofit Innovation
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...Nguyen Thanh Tu Collection
https://app.box.com/s/qhtvq32h4ybf9t49ku85x0n3xl4jhr15RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Physical pharmaceutics notes for B.pharm students
PCOS corelations and management through Ayurveda.
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
The Diamonds of 2023-2024 in the IGRA collection
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Librarians are leading the way in creating future-ready citizens – now we need to update our spaces to match. In this session, attendees will get inspiration for transforming their library spaces. You’ll learn how to survey students and patrons, create a focus group, and use design thinking to brainstorm ideas for your space. We’ll discuss budget friendly ways to change your space as well as how to find funding. No matter where you’re at, you’ll find ideas for reimagining your space in this session.
How to deliver Powerpoint Presentations.pptx
"How to make and deliver dynamic presentations by making it more interactive to captivate your audience attention"
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxMohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
Walmart Business+ and Spark Good for Nonprofits.pdf
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
The History of Stoke Newington Street Names
Presented at the Stoke Newington Literary Festival on 9th June 2024
www.StokeNewingtonHistory.com
Recently uploaded (20)
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
Retinopathy of prematurity
- 1. Retinopathy of Prematurity (ROP)
- 2. PBMA’S H. V. DESAI EYE HOSPITAL Learning Objectives: At the end of this lecture you should be able to know - What is ROP? - Why is ROP relevant for India? - Who are at risk of ROP? - When to screen for ROP and screening methods.
- 3. PBMA’S H. V. DESAI EYE HOSPITAL Let’s start with a quiz… • ROP is a disease of… -cornea - retina - lens • ROP occurs in… - school children - infants - old persons
- 4. PBMA’S H. V. DESAI EYE HOSPITAL • Potential impact of ROP on vision… - no impact - blindness - mild blurring of vision
- 5. PBMA’S H. V. DESAI EYE HOSPITAL • Definition - Vascular disorder of the retina which occurs principally in the preterm infants. • Specifically, occurs in the incompletely vascularized retina. • May lead to permanent blindness in a child. Introduction
- 6. PBMA’S H. V. DESAI EYE HOSPITAL Likely distribution of blindness in children due to retinopathy of prematurity using infant mortality rates as an indicator. [Eye 2007 21: 1338−43]. Why do you think IMR can be a proxy indicator for estimating distribution of ROP blindness??
- 7. PBMA’S H. V. DESAI EYE HOSPITAL Courtesy: Prof. Clare Gilbert, LSHTM, London
- 8. PBMA’S H. V. DESAI EYE HOSPITAL Why should we care? Poverty relationship s Development Isolation Impact of Blindness*- 1. Kulkarni, S; Gilbert, C; Zuurmond, M ; Agashe S; Deshpande M. Blinding Retinopathy of Prematurity in Western India: Characteristics of Children, Reasons for Late Presentation and Impact on Families. 2018;55:665–70.
- 9. PBMA’S H. V. DESAI EYE HOSPITAL Can you differentiate between ‘normal’ and ‘abnormal’?
- 10. PBMA’S H. V. DESAI EYE HOSPITAL ROP : Who is at risk? -Preterm (born < 34 weeks of pregnancy) - low birth weight (< 2Kg ) infants OR - Bigger Infants (> 2kg) with critical illness during first month after birth Biggest baby treated by us- 2.4 kg BW
- 11. PBMA’S H. V. DESAI EYE HOSPITAL Risk Factors: • Prematurity - <34 weeks/ < 2kg • ‘Unmonitored’ oxygen supply • Infection (sepsis) • Anemia requiring Blood transfusion • Multiple births and many more…..
- 12. PBMA’S H. V. DESAI EYE HOSPITAL ROP screening : Why? • Premature babies are not born with the disease • ROP starts developing after 2-3 weeks of birth. • Blindness preventable with timely treatment in most cases.
- 13. PBMA’S H. V. DESAI EYE HOSPITAL ROP Screening - When Govt of India guidelines 2017 • First screening: at or before Day 30 of life • For extremely premature baby(<1200 gm/ <30 weeks): Day 20
- 14. PBMA’S H. V. DESAI EYE HOSPITAL Screening: How? Indirect Ophthalmoscopy
- 15. PBMA’S H. V. DESAI EYE HOSPITAL Screening: How? Imaging with a Digital Camera
- 16. PBMA’S H. V. DESAI EYE HOSPITAL Do all preterm babies develop ROP? • Less than half 20-44% (Indian reports) • Sight threatening ROP: 3-10% • Only sight threatening ROP requires laser treatment/ injections. • Complications of ROP (retinal detachment) require surgery. Good news: 90/100 preterm babies DO NOT develop blinding ROP.
- 17. Stage 1 Stage 2 Stage 3 Stage 4 APROP Post Laser stage 5 How does ROP look like?
- 18. PBMA’S H. V. DESAI EYE HOSPITAL Is a preterm child free of risk once ROP is taken care of? • No • Other ocular diseases not uncommon in preterm*: - High myopia - Amblyopia, squint - Cataract, glaucoma - Delayed visual maturation - Retinal detachment 1. Kulkarni Sucheta; Shah Mukti, Dole Kuldeep et al. Ocular Outcomes and Co-morbidities in preterm infants enrolled for Retinopathy of Prematurity screening: a Cohort study from Western India. Oman J Ophthalmol. 2018;
- 19. PBMA’S H. V. DESAI EYE HOSPITAL Need of follow up • Every 3 months till 1 yr of age. • Every 6 months thereafter till 3 yrs. • Annual check up after 3 yrs. Laser treated babies need lifelong follow up.
- 20. PBMA’S H. V. DESAI EYE HOSPITAL What can we do to prevent ROP? • Not possible in ALL cases but… • Tight monitoring of oxygen supply • Hand hygiene (prevent infection) • Mother’s milk- weight gain, reduced infection
- 21. PBMA’S H. V. DESAI EYE HOSPITAL KBC Time again…….. • Write your ‘code number’ on the top of a sheet of paper. • Write your answers in front of question number. (Example- Q 1- b, Q 3- a and so on) • Exchange your answer sheet with your neighbor after completion. • Check your neighbor’s answers- One mark for each correct answer.
- 22. PBMA’S H. V. DESAI EYE HOSPITAL 1. Blindness from ROP is preventable. a. True b. False 2. Birth weight cut off for ROP screening. a. 1 kg b. 2 kg c. 2.5 kg
- 23. PBMA’S H. V. DESAI EYE HOSPITAL 3. What can a mother do to reduce risk of ROP in her child? a. Oxygen monitoring b. Observe eyes c. breastfeeding
- 24. PBMA’S H. V. DESAI EYE HOSPITAL 4. What will you advise to a family of newborn preterm baby? a. Ask your pediatrician about ROP screening. b. Go to any ophthalmologist for ROP check up. c. Go to a nearby PHC for screening.
- 25. PBMA’S H. V. DESAI EYE HOSPITAL 5. Your neighbor’s preterm child (BW 1.5 kg) is now 2 weeks old and discharged from NICU. Parents were told about eye check up but not told when? When would you advise them to get their child’s ROP screening done? At or before- a. 3 months b. 6 months c. 1 month Exchange your answer sheet with your neighbor and give 1 mark for each correct answer.
- 26. PBMA’S H. V. DESAI EYE HOSPITAL Thank you!!!
Editor's Notes
- 1
- 2
- 3
- 4
- 5
- 8
- 9
- 10
- 11
- 12
- 16
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26